| Literature DB >> 35999943 |
Meg Stone-Heaberlin1,2, Nick Hartley1, James D Lynch3, Allison P Fisher3, Natalie Justice1,2.
Abstract
For young children with autism spectrum disorder (ASD), early intensive intervention is imperative. The Bridge Skill Development Program is a parent-mediated intervention designed to "bridge the gap" during the period after a diagnosis of ASD while children wait for intensive intervention. This program introduces applied behavior analysis (ABA) teaching techniques, including the use of parent-mediated discrete trial teaching (DTT), to promote skill acquisition of target behaviors. Significant improvements were observed across four target behaviors taught to all participants. The program also aims to connect participants to intensive ABA programming. © Association for Behavior Analysis International 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.Entities:
Keywords: Autism; Discrete trial teaching; Early intervention; Parent-mediated
Year: 2022 PMID: 35999943 PMCID: PMC9388204 DOI: 10.1007/s40617-022-00735-3
Source DB: PubMed Journal: Behav Anal Pract ISSN: 1998-1929
Pre- to post-treatment improvements in skill development
| Pretreatment | Postreatment | ||||
|---|---|---|---|---|---|
| M ( | M ( | Cohen’s | |||
| Skills Mastereda | 27.8 (15.7) | 71.9 (18.9) | 12.88 | <.001 | 2.54 |
| Core Target Behaviorsb | |||||
| Eye Contact | 78.3 (24.6) | 93.5 (8.1) | 3.10 | .005 | 0.83 |
| Imitating Object Use | 58.7 (36.3) | 94.3 (9.2) | 4.81 | <.001 | 1.34 |
| Matching Objects | 48.7 (40.1) | 86.4 (14.3) | 4.72 | <.001 | 1.25 |
| Following Instructions | 49.1 (41.2) | 89.5 (18.2) | 4.79 | <.001 | 1.27 |
Mastery is considered to be 80% correct response or higher
aPercentage of assessed skills mastered at pre- and post-treatment
bPercentage (correct out of 10 trials) at pre- and post-treatment